The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.
about
A unique case of concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and lymphomatoid papulosis in the same biopsy.Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia.Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study.Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients.
P2860
The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The value of rituximab for the ...... ve analysis of the literature.
@ast
The value of rituximab for the ...... ve analysis of the literature.
@en
type
label
The value of rituximab for the ...... ve analysis of the literature.
@ast
The value of rituximab for the ...... ve analysis of the literature.
@en
prefLabel
The value of rituximab for the ...... ve analysis of the literature.
@ast
The value of rituximab for the ...... ve analysis of the literature.
@en
P2093
P2860
P1433
P1476
The value of rituximab for the ...... ve analysis of the literature.
@en
P2093
Ann Janssens
Eugene Nikitin
Stéphane Lepretre
Tadeusz Robak
Veronique Leblond
P2860
P304
P356
10.3109/10428194.2011.631636
P577
2011-12-13T00:00:00Z